MaxWell Biomedical
PrivateLast Round
Grant
Sep 15, 2022
Total Funding Raised
$2.3M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
MaxWell Biomedical operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Grant round in September 2022.
MaxWell Biomedical is a medical technology company developing a device-based solution, Spatial Resynchronization Therapy (SRT), for atrial fibrillation (AFib) and heart failure.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Health IoT
Business Model
B2B
Customer Profile
Hardware + Subscription, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MaxWell Biomedical Comparables
Compare MaxWell Biomedical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AtaCor Medical | 74% | |
| Medtronic | 71% | |
| Kobara Medical, Inc. | 69% |
For institutional investors. Book with your work email.
MaxWell Biomedical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 15, 2022 | ||||
| Angel | Aug 4, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
MaxWell Biomedical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SeedFolio | Angel |
| National Heart, Lung, and Blood Institute | Grant |
| TCA Venture Group | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 103% MoM, reaching 970.
- Jul 27, 2026
Grew 23% QoQ, from 13 to 16 employees.
For institutional investors. Book with your work email.
MaxWell Biomedical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about MaxWell Biomedical's valuation, stock price, and market status.
Is MaxWell Biomedical a public or private company?
MaxWell Biomedical is a private company.
What is the current stock price of MaxWell Biomedical?
MaxWell Biomedical is a private company, so its shares have no public market price. Caplight tracks MaxWell Biomedical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MaxWell Biomedical worth (valuation)?
Valuation information for MaxWell Biomedical is not publicly available.
Can I buy MaxWell Biomedical stock?
MaxWell Biomedical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MaxWell Biomedical's last funding round?
MaxWell Biomedical's most recent funding round was Grant on September 15, 2022.
Who are the main investors in MaxWell Biomedical?
Key investors in MaxWell Biomedical include National Heart, Lung, and Blood Institute.
Will MaxWell Biomedical IPO soon?
No public IPO plans have been announced for MaxWell Biomedical.
How can I track MaxWell Biomedical secondary market activity?
Caplight tracks bids, offers, and trades in MaxWell Biomedical's shares on secondary markets.